Table 1.
OUTCOMES | 3 MONTHS | 6 MONTHS | 12 MONTHS | ||||||
---|---|---|---|---|---|---|---|---|---|
Clinical | + | − | NA | + | − | NA | + | − | NA |
Soft tissue pathology | 0 | 22 (100%) | 0 | 1 (4.5%) | 20 (90.9%) | 1 (4.5%) | 1 (4.5%) | 19 (86.3%) | 2 (9.0%) |
Pain to percussion | 0 | 22 (100%) | 0 | 1 (4.5%) | 20 (90.9%) | 1 (4.5%) | 1 (4.5%) | 19 (86.3%) | 2 (9.0%) |
Pathologic mobility | 0 | 22 (100%) | 0 | 1 (4.5%) | 20 (90.9%) | 1 (4.5%) | 1 (4.5%) | 19 (86.3%) | 2 (9.0%) |
Radiological | + | − | NA | + | − | NA | + | − | NA |
Pathologic radiolucency | - | - | - | 1 (4.5%) | 20 (90.9%) | 1 (4.5%) | 1 (4.5%) | 19 (86.3%) | 2 (9.0%) |
Pathologic root resorption | - | - | - | 1 (4.5%) | 20 (90.9%) | 1 (4.5%) | 1 (4.5%) | 19 (86.3%) | 2 (9.0%) |
Composite score | 1 (4.5%) | 20 (90.9%) | 1 (4.5%) | 1 (4.5%) | 19 (86.3%) | 2 (9.0%) |
+: Positive; −: Negative; NA: not applicable, defining the cases that could not be evaluated due to physiologic factors such as the eruption of successors.